Chewy ve 2. čtvrtletí zvýšil tržby na 3,33 miliardy USD, meziročně o 7,3 %, a zároveň zvedl celoroční výhled tržeb i marže EBITDA. Firma dál získává podíl na trhu díky růstu aktivních zákazníků a Autoship.
Chewy’s Growth Engine Is Stronger Than the Market ThinksChewy NYSE: CHWY reported second-quarter fiscal 2026 net sales of $3.33 billion, up 7.3% from a year earlier and at the high end of its guidance range, as active customer growth, higher spending per customer and Autoship sales supported results amid continued pressure on pet-sector discretionary spending.
Chief Executive Officer Sumit Singh said the broader pet market did not experience a meaningful consumer recovery during the quarter, though conditions also did not worsen from the trends seen at the end of the first quarter. He said Chewy continued to outperform the broader pet category by roughly two to three times and gain market share.
Get Chewy alerts:
From CrowdStrike to Chewy, These Tanking Stocks Are Announcing BuybacksExcluding contributions from acquired businesses SmartPak and Modern Animal, organic net sales rose 5.7% year over year. The company ended the quarter with 21.7 million active customers, an increase of 3.8%, while net sales per active customer reached $602.
Autoship customer sales climbed 9.3% to $2.8 billion and represented 84.6% of total net sales. Singh said the recurring-sales model remains a key source of revenue durability, while Chewy continued to add customers, improve retention, reactivate lapsed customers and expand engagement across its ecosystem.
Consumer Spending Remains Selective Chewy Gobbles up Market Share in 2026: Poised to Advance in Q2Chewy said pressure on discretionary purchases and premiumization continued during the quarter, affecting both Consumables and Hardgoods. Singh said consumers remained focused on core food, medications and health-oriented products, while treats and toppers were more exposed to discretionary spending pressures.
Chief Financial Officer Chris Deppe said treats sales growth slowed more sharply than sales of core food. Still, he said industry data indicated that the broader Consumables market was roughly flat year over year, while Chewy delivered mid-single-digit growth in the category. Hardgoods sales increased in the mid-teens, supported by assortment and merchandising improvements, according to the company.
Singh said pet-industry conditions reflected both consumer pressures and softness in dog adoption and household formation. He added that Chewy does not expect pricing to provide a material benefit to sales growth this year, though the company also does not anticipate broad category deflation or irrational promotional activity.
Profitability Exceeds Expectations, With Timing Benefits Adjusted EBITDA totaled $227 million, representing a 6.8% margin and exceeding Chewy’s prior guidance of 6.3% to 6.4%. Adjusted net income was $149 million, or $0.36 per diluted share.
Deppe said essentially all of the outperformance relative to the company’s margin expectations came from timing-related and discrete benefits. About $10 million of the benefit came primarily from tariff refunds received earlier than anticipated and rebates that shifted from the second half into the second quarter. The quarter also included more than $5 million of benefits from gift-card breakage, inventory adjustments and vendor-funded merchandising activity.
Gross margin was 30.4%, flat year over year and up 30 basis points from the first quarter. Deppe said the company expects gross margin to decline modestly sequentially in the third quarter, in line with seasonal patterns, although it expects gross margin to expand for the full year at a more moderate pace than in fiscal 2025.
Non-GAAP selling, general and administrative expense was 18.4% of sales, compared with 19.1% a year earlier. The company cited improved fulfillment-center utilization, lower variable costs to serve, headcount discipline, automation and AI-enabled productivity as drivers of 70 basis points of year-over-year SG&A leverage.
Health, Acquisitions and AI Remain Strategic Priorities Chewy said its health businesses continued to expand. The Chewy Vet Care clinic portfolio delivered triple-digit revenue growth, while the company said Modern Animal performed ahead of its expectations following its acquisition. Chewy completed the $400 million Modern Animal acquisition during the quarter.
Singh said Modern Animal and Chewy Vet Care offer complementary capabilities, unit economics and telehealth offerings. SmartPak, Chewy’s equine, farm and exotics business, also performed ahead of expectations. The business recorded its seventh consecutive quarter of mid-double-digit year-over-year sales growth, according to Singh.
The company also highlighted progress in deploying artificial intelligence across customer service, pharmacy and veterinary operations. Chewy launched its AI-powered customer assistant, Kai, to a select group of mobile-app users. Singh said about 30% of chats were resolved through self-service for common requests involving orders, returns, Autoship and account management.
Chewy also began using AI tools for customer-care agents and pharmacy workflows, while its Callie voice capability is supporting appointment confirmations, scheduling and follow-ups at select Chewy Vet Care locations. The company expects AI initiatives to generate low tens of millions of dollars in cost savings during fiscal 2026 and about $50 million on an annualized basis in fiscal 2027.
Singh cautioned that AI savings should not be viewed as a standalone amount that will flow directly to the bottom line, as the company expects the efficiencies to offset ordinary cost pressures and potentially fund growth investments.
Guidance Raised and Narrowed Chewy raised and narrowed its fiscal 2026 outlook, citing more stable consumer trends, continued market-share gains and better-than-expected contributions from SmartPak and Modern Animal. The company now expects full-year net sales of $13.46 billion to $13.57 billion, representing growth of 6.8% to 7.7%.
Organic net sales are expected to grow 5.5% to 6.3% for the year. The company said the midpoint of the forecast does not assume a meaningful improvement in consumer conditions.
Full-year adjusted EBITDA margin is expected to be 6.7% to 6.8%, compared with prior guidance of 6.6% to 6.8%. At the midpoint, the outlook implies adjusted EBITDA of $912 million and more than 100 basis points of year-over-year margin expansion. Third-quarter net sales are projected at $3.323 billion to $3.358 billion, with adjusted EBITDA margin of 6.6% to 6.7% and adjusted diluted earnings per share of about $0.39. Chewy generated $90 million in free cash flow during the quarter and ended the period with $612 million in cash equivalents and marketable securities, as well as more than $1 billion in total available liquidity. The company issued $600 million in term loans and repurchased $200 million of stock, buying back 9.9 million shares during the quarter.
About Chewy (NYSE:CHWY)Chewy, Inc NYSE: CHWY is a leading e-commerce retailer specializing in pet food, supplies and services. The company offers a comprehensive assortment of products for dogs, cats, fish, birds and other small animals, including prescription medications, veterinary health products, grooming essentials and toys. Through its online platform and mobile app, Chewy provides an intuitive shopping experience with features such as Autoship, ensuring regular deliveries of pet essentials at schedule intervals.
Founded in 2011 by Ryan Cohen and Michael Day, Chewy initially operated under the name Mr.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Chewy Right Now?Before you consider Chewy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chewy wasn't on the list.
While Chewy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Chewy ve 2. čtvrtletí překonal odhady tržeb i zisku na akcii, ale akcie klesly o 8,6 % po zklamání ve volném peněžním toku. Ten spadl na 89,5 milionu USD, pod očekávaných 133 milionů USD.
Chewy Inc (NYSE:CHWY) reported second-quarter revenue and profit above Wall Street estimates on Thursday, even as shares fell 8.6% after the pet products retailer's free cash flow missed expectations.
Revenue rose 7.3% year-over-year to $3.33 billion, edging past the $3.32 billion analysts had forecast. Adjusted earnings per share came in at $0.36, up 9.1% from a year earlier.
Adjusted EBITDA climbed 23.7% to $226.7 million, topping estimates of $211 million, while adjusted EBITDA margin expanded 90 basis points to 6.8%, also ahead of forecasts.
Gross margin held steady at 30.4% year-over-year, and net margin improved 40 basis points to 2.4%. Free cash flow fell 15.5% to $89.5 million, well short of the $133 million analysts had expected.
Active customers grew 3.8% to 21.705 million.
Analysts at Jefferies said the company's base business, excluding acquisitions, is holding up, which they said should be viewed favorably given softer macroeconomic commentary in the prior quarter. However, they noted that one-time items and timing factors contributed to the profit beat, and that guidance pointing to stable core growth alongside heavy reinvestment means the results are not as strong as headline numbers suggest.
The analysts said Chewy's capital deployment toward expanding its addressable market in veterinary and equestrian categories is a sensible move, and that its artificial intelligence and membership initiatives show promise, though the timing of when those investments will generate higher returns remains uncertain.
Chewy zveřejní hospodářské výsledky za 2. čtvrtletí ve středu před otevřením trhu; analytici čekají EPS 36 centů a výnosy 3,32 miliardy USD. Akcie v pátek klesly o 1,3 % na 23,66 USD.
Chewy, Inc. (NYSE:CHWY) will release its second earnings report before the opening bell on Wednesday, Sept. 9.
Analysts expect the Plantation, Florida-based company to report quarterly earnings of 36 cents per share, up from 33 cents per share in the year-ago period. The consensus estimate for CHWY’s quarterly revenue is $3.32 billion. It reported $3.1 billion last year, according to Benzinga Pro.
On June 10, Chewy reported better-than-expected first-quarter results, but the online pet retailer lowered its fiscal 2026 sales outlook.
Chewy shares fell 1.3% to close at $23.66 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
RBC Capital analyst Steven Shemesh maintained an Outperform rating with a price target of $34 on Aug. 26, 2026. This analyst has an accuracy rate of 59%. Rosenblatt analyst Scott Devitt initiated coverage on the stock with a Neutral rating and a price target of $25 on Aug. 20, 2026. This analyst has an accuracy rate of 80%. UBS analyst Michael Lasser maintained a Neutral rating and cut the price target from $32 to $24 on June 11, 2026. This analyst has an accuracy rate of 78%. JP Morgan analyst Doug Anmuth maintained an Overweight rating and slashed the price target from $35 to $29 on June 11, 2026. This analyst has an accuracy rate of 84%. Citizens analyst Andrew Boone maintained a Market Outperform rating and cut the price target from $45 to $28 on June 11, 2026. This analyst has an accuracy rate of 72%. Trending
Considering buying CHWY stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Chewy uzavřela na 23,80 USD, což představuje denní růst o 2,32 % a lepší výkon než širší trh. Investoři sledují výsledky hospodaření, které má firma oznámit 9. září 2026.
In the latest trading session, Chewy (CHWY - Free Report) closed at $23.80, marking a +2.32% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.33%. On the other hand, the Dow registered a loss of 0.7%, and the technology-centric Nasdaq decreased by 0.12%.
Coming into today, shares of the online pet store had gained 2.92% in the past month. In that same time, the Retail-Wholesale sector gained 2.78%, while the S&P 500 gained 3.87%.
The upcoming earnings release of Chewy will be of great interest to investors. The company's earnings report is expected on September 9, 2026. The company is expected to report EPS of $0.36, up 9.09% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $3.32 billion, indicating a 6.83% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $1.53 per share and revenue of $13.49 billion, which would represent changes of +20.47% and +7.06%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Chewy. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate has moved 0.31% lower within the past month. Chewy is currently sporting a Zacks Rank of #4 (Sell).
Valuation is also important, so investors should note that Chewy has a Forward P/E ratio of 15.25 right now. This signifies a discount in comparison to the average Forward P/E of 17.22 for its industry.
It's also important to note that CHWY currently trades at a PEG ratio of 0.62. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As the market closed yesterday, the Internet - Commerce industry was having an average PEG ratio of 1.24.
The Internet - Commerce industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 101, which puts it in the top 42% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Chewy uzavřela o 3,99 % níže na 22,59 USD, tedy hůře než S&P 500. Před zveřejněním výsledků analytici očekávají zisk 0,36 USD na akcii a tržby 3,32 miliardy USD.
In the latest trading session, Chewy (CHWY - Free Report) closed at $22.59, marking a -3.99% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.06% for the day. Elsewhere, the Dow saw a downswing of 0.11%, while the tech-heavy Nasdaq depreciated by 0.32%.
Coming into today, shares of the online pet store had gained 12.69% in the past month. In that same time, the Retail-Wholesale sector gained 7.55%, while the S&P 500 gained 3.42%.
The investment community will be paying close attention to the earnings performance of Chewy in its upcoming release. In that report, analysts expect Chewy to post earnings of $0.36 per share. This would mark year-over-year growth of 9.09%. Meanwhile, our latest consensus estimate is calling for revenue of $3.32 billion, up 6.83% from the prior-year quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $1.53 per share and revenue of $13.49 billion, indicating changes of +20.47% and +7.2%, respectively, compared to the previous year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Chewy. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Chewy presently features a Zacks Rank of #4 (Sell).
Digging into valuation, Chewy currently has a Forward P/E ratio of 15.4. For comparison, its industry has an average Forward P/E of 18.55, which means Chewy is trading at a discount to the group.
It's also important to note that CHWY currently trades at a PEG ratio of 0.62. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Internet - Commerce industry held an average PEG ratio of 1.18.
The Internet - Commerce industry is part of the Retail-Wholesale sector. This industry, currently bearing a Zacks Industry Rank of 163, finds itself in the bottom 34% echelons of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Chewy uzavřela na 22,82 USD, což znamená denní pokles o 2,06 % i přes růst širšího trhu. Investoři sledují nadcházející výsledky, kde se čeká EPS 0,36 USD a výnosy 3,32 miliardy USD.
In the latest trading session, Chewy (CHWY - Free Report) closed at $22.82, marking a -2.06% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 1.66%. At the same time, the Dow added 1.19%, and the tech-heavy Nasdaq gained 2.78%.
Coming into today, shares of the online pet store had gained 13.11% in the past month. In that same time, the Retail-Wholesale sector gained 0.61%, while the S&P 500 lost 1.49%.
The upcoming earnings release of Chewy will be of great interest to investors. The company is predicted to post an EPS of $0.36, indicating a 9.09% growth compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $3.32 billion, indicating a 6.83% upward movement from the same quarter last year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $1.53 per share and a revenue of $13.49 billion, representing changes of +20.47% and +7.06%, respectively, from the prior year.
Any recent changes to analyst estimates for Chewy should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Chewy possesses a Zacks Rank of #5 (Strong Sell).
Valuation is also important, so investors should note that Chewy has a Forward P/E ratio of 15.25 right now. This signifies a discount in comparison to the average Forward P/E of 16.71 for its industry.
It's also important to note that CHWY currently trades at a PEG ratio of 0.62. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The average PEG ratio for the Internet - Commerce industry stood at 1.27 at the close of the market yesterday.
The Internet - Commerce industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 181, putting it in the bottom 27% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Chewy vidí péči o zvířata jako klíčový dlouhodobý růstový motor a po akvizici Modern Animal čeká zhruba 60 klinik do konce fiskálního roku 2026. Síť Vet Care má přitahovat nové zákazníky a zvyšovat útraty stávajících.
Key Takeaways Chewy sees pet healthcare as a major growth opportunity, supported by its Vet Care clinic network.CHWY's Vet Care clinics attract new customers and increase spending from existing customers.CHWY expects Modern Animal to accelerate clinic expansion to about 60 locations by fiscal 2026. Chewy, Inc. (CHWY - Free Report) believes pet healthcare remains one of its largest long-term growth opportunities, supported by an estimated total addressable market of around $54 billion. Chewy Vet Care clinics continue to generate strong stand-alone economics while serving as effective customer acquisition and retention channels for the broader ecosystem. The shortage of veterinarians also provides Chewy with a structural advantage as it expands its veterinary clinic network.
To support this strategy, the company completed the acquisition of Modern Animal. Management noted that Modern Animal adds a complementary clinic footprint, strong clinical expertise and a technology-enabled operating model aligned with Chewy Vet Care. The acquisition is expected to accelerate clinic expansion by combining Chewy Vet Care’s organic growth with Modern Animal’s existing footprint and development pipeline, with the combined business projected to operate approximately 60 clinics by the end of fiscal 2026 and generate an embedded steady-state revenue contribution of about $290 million.
The company noted that Chewy Vet Care continues to strengthen the broader Chewy ecosystem by attracting new customers to the platform while encouraging existing customers to increase their spending following their initial clinic visit. This demonstrates the strategic value of its integrated pet healthcare offering by supporting customer acquisition, retention and a greater share of wallet, while reinforcing the company's long-term growth strategy.
Additionally, technology-enabled workflows and AI-assisted tools are driving strong veterinary productivity, retention and employee satisfaction. Combined with Chewy’s recurring revenue model, scaled fulfillment network and expanding healthcare platform, these capabilities support its long-term 10% adjusted EBITDA margin target. Overall, Chewy's expanding healthcare ecosystem strengthens its competitive moat by enhancing customer acquisition, retention and share of wallet while supporting long-term profitability.
Zacks Rundown for CHWYCHWY shares have lost 25.3% in the past three months compared with the industry’s 2.6% decline. The company carries a Zacks Rank #5 (Strong Sell) at present.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a forward price-to-earnings ratio of 21.74, lower than the industry’s average of 21.84.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for earnings for the current and next fiscal year indicates year-over-year growth of 20.5% and 21.7%, respectively.
Image Source: Zacks Investment Research
Stocks to ConsiderSome better-ranked stocks have been discussed below:
Phibro Animal Health Corporation (PAHC - Free Report) operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. PAHC currently carries a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for PAHC's current fiscal-year sales and earnings implies growth of 14.8% and 47.4%, respectively, from the year-ago actuals. PAHC delivered a trailing four-quarter earnings surprise of 16.3%, on average.
Carvana Co. (CVNA - Free Report) , currently carrying a Zacks Rank #2, operates an e-commerce platform for buying and selling used cars.
The Zacks Consensus Estimate for CVNA’s current financial-year sales implies growth of 38.5%, and the same for earnings implies a decline of 6.5% from the year-ago reported numbers. CVNA delivered a negative trailing four-quarter earnings surprise of 71.6%, on average.
Amazon.com Inc. (AMZN - Free Report) engages in the retail sale of consumer products, advertising, and subscription services through online and physical stores in North America and internationally. At present, Amazon carries a Zacks Rank of 2.
The consensus estimate for Amazon’s current fiscal-year sales and earnings implies growth of 15.2% and 29.6%, respectively, from the year-ago figures. AMZN delivered a trailing four-quarter earnings surprise of 11.4%, on average.
Chewy uvádí, že růst opakovaných tržeb táhne vyšší počet aktivních zákazníků i vyšší útrata na zákazníka. Kliniky Chewy Vet Care přivádějí nové klienty a posilují loajalitu v ekosystému Autoship.
Key Takeaways Chewy's recurring revenues are supported by customer growth and higher spending per active customer.CHWY's Vet Care clinics attract new customers and help increase spending from existing customers.CHWY's Autoship ecosystem and value proposition continue to support loyalty and market share gains. Chewy, Inc. (CHWY - Free Report) highlighted the continued strength of its recurring revenue base, supported by a balanced contribution from both active customer growth and the Net Sales Per Active Customer (NSPAC) expansion. Management believes that the pet category remains resilient, supported by recurring non-discretionary spending and strong emotional attachment between pet owners and their pets. Despite a more challenging operating environment, the company continues to gain market share steadily within the category.
The company views Chewy Health and Chewy Vet Care to be among its most significant long-term growth opportunities. Chewy Vet Care clinics continue to deliver strong stand-alone economics while supporting customer acquisition and retention across the broader Chewy ecosystem. Around 40% of clinic customers are new to Chewy and generate approximately $900 in first-year NSPAC. In addition, existing Chewy customers who visit Chewy Vet Care increase their share of wallet at a meaningfully faster rate after their initial clinic visit.
Chewy’s value proposition continues to differentiate it through industry-leading convenience, competitive pricing, trusted service, a broad product assortment and its recurring Autoship ecosystem. Management noted that these strengths become even more relevant during periods when consumers prioritize value, reliability and trusted relationships. The company believes this combination reinforces customer loyalty, supports sustained demand and strengthens its competitive positioning within the pet category.
Overall, Chewy’s integrated ecosystem continues to strengthen its competitive position by deepening customer relationships and increasing customer lifetime value. Consistent execution of this strategy should support durable market share gains and sustainable long-term profitable growth.
Zacks Rundown for CHWYCHWY shares have lost 32.3% in the past six months compared with the industry’s 7.6% decline. The company carries a Zacks Rank #5 (Strong Sell) at present.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a forward price-to-earnings ratio of 22.77, higher than the industry’s average of 21.38.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for earnings for the current and next fiscal year indicates year-over-year growth of 20.5% and 21.7%, respectively.
Image Source: Zacks Investment Research
Stocks to ConsiderSome better-ranked stocks have been discussed below:
Central Garden & Pet Company (CENT - Free Report) produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for CENT’s current financial-year sales implies a decline of 5.7%, and the same for earnings implies growth of 5.9% from the year-ago reported numbers. CENT delivered a trailing four-quarter earnings surprise of 45.4%, on average.
Phibro Animal Health Corporation (PAHC - Free Report) operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. PAHC presently carries a Zacks Rank of 2 (Buy).
The Zacks Consensus Estimate for PAHC's current fiscal-year sales and earnings implies growth of 14.8% and 47.4%, respectively, from the year-ago actuals. PAHC delivered a trailing four-quarter earnings surprise of 16.3%, on average.
Trupanion, Inc. (TRUP - Free Report) together with its subsidiaries, provides medical insurance for cats and dogs on a subscription basis in the United States, Canada, Continental Europe, and Australia. It currently holds a Zacks Rank #2.
The Zacks Consensus Estimate for TRUP’s current financial-year sales and earnings indicates 9.4% and 20% growth from the last year, respectively. TRUP reported a trailing four-quarter average earnings surprise of 250%.
Chewy rozšiřuje AI a automatizaci napříč zákaznickou podporou, lékárenskou činností i logistikou a čeká z nich v roce 2026 úspory v nižších desítkách milionů dolarů. V 1. čtvrtletí už díky nim vykázala zhruba 90 bazických bodů meziroční páky v SG&A.
Key Takeaways Chewy is scaling AI across customer service, pharmacy, fulfillment and marketing workflows.CHWY expects AI initiatives to deliver efficiency gains in the low tens of millions of dollars in fiscal 2026.Chewy reported 90 basis points of year-over-year SG&A leverage, aided by productivity and early AI benefits. Chewy, Inc. (CHWY - Free Report) is expanding the use of artificial intelligence ("AI") and automation across its business to enhance customer service and improve operational efficiency. During the first quarter of fiscal 2026, the company built the infrastructure required to deploy AI at scale and began integrating these capabilities across multiple functions to support its long-term growth strategy.
Chewy is applying AI and automation across customer service, pharmacy operations, fulfillment and marketing workflows. Management noted that these initiatives are helping lower the cost of serving customers by improving workflow speed, service quality and productivity. The company is utilizing AI to enhance search relevance, personalization and marketing effectiveness.
Chewy expects AI-driven initiatives to generate efficiency benefits in the low tens of millions of dollars during fiscal 2026, with a more meaningful contribution anticipated in 2027 and beyond. In the first quarter, the company delivered roughly 90 basis points of year-over-year SG&A leverage, supported by fulfillment productivity gains, operating discipline and early benefits from technology, automation and AI-enabled initiatives.
At the same time, Chewy continues to invest in strategic growth initiatives, including expanding Chewy Health, scaling Chewy Vet Care, optimizing its fulfillment network and strengthening customer acquisition capabilities. Management emphasized that investments in AI infrastructure and automation are designed not only to improve near-term productivity but also to reinforce the company's long-term competitive positioning.
Looking ahead, management believes continued investments across health, AI, automation, fulfillment and customer experience will strengthen the Chewy ecosystem. The company reiterated the long-term adjusted EBITDA margin target of 10%, reflecting confidence in the operating model as it balances innovation, automation and disciplined execution.
CHWY’s Price Performance, Valuation & EstimatesChewy, which competes with BARK, Inc. (BARK - Free Report) and Petco Health and Wellness Company, Inc. (WOOF - Free Report) , has fallen 28% over the past three months against the industry’s growth of 5.5%. Meanwhile, BARK's shares have declined 5.4% and Petco has dipped 1%.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a trailing price-to-sales ratio of 0.63X, below the industry’s average of 2.10X. It has a Value Score of A. CHWY is trading at a premium to BARK (with a trailing 12-month P/S ratio of 0.21) and Petco (0.13).
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CHWY’s fiscal 2026 and 2027 earnings implies year-over-year growth of 20.5% and 21.9%, respectively. Estimates for fiscal 2026 and 2027 have been revised downward by 9 cents and 13 cents, respectively, over the past 30 days.
Image Source: Zacks Investment Research
Although the company continues to invest in AI, healthcare and fulfillment capabilities to support long-term growth, short-term challenges remain. Management expects margin expansion to moderate amid difficult comparisons, higher transportation-related costs and continued strategic investments. A softer consumer spending environment and a more cautious outlook for discretionary categories could limit revenue growth and operating leverage in the near term. CHWY currently carries a Zacks Rank #5 (Strong Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Chewy kupuje Modern Animal, aby posílil veterinární péči a do fiskálního roku 2026 míří na 60 klinik. Modern Animal má v roce 2026 přinést 70 milionů USD tržeb.
Key Takeaways CHWY acquired Modern Animal to expand its veterinary care platform and healthcare ecosystem.CHWY expects roughly 60 clinics by FY26 through combined expansion plans.Modern Animal is projected to contribute $70M to FY26 revenues for CHWY. Chewy, Inc. (CHWY - Free Report) is accelerating its push into pet healthcare through the acquisition of Modern Animal, a technology-enabled veterinary care provider. The deal strengthens Chewy’s presence in the highly attractive and underpenetrated pet healthcare market while supporting its broader strategy of building a comprehensive ecosystem that spans products, pharmacy and veterinary services. Management believes that the company is well-positioned to capitalize on this opportunity as demand for pet healthcare continues to grow.
A key advantage for Chewy is its growing access to veterinary talent in an industry facing a shortage of veterinarians. Management noted that this creates a structural advantage as the company expands its Chewy Vet Care network. Modern Animal adds a highly complementary platform with strong clinical expertise, above-industry unit economics and an experience-led, technology-enabled model that aligns closely with Chewy’s veterinary strategy.
The acquisition is expected to accelerate clinic expansion by combining Chewy Vet Care’s organic growth initiatives with Modern Animal’s existing footprint and development pipeline. Together, the businesses are expected to operate 60 clinics by the end of fiscal 2026, with embedded revenue contribution approaching $290 million at steady state.
Chewy has also incorporated the acquisition into its fiscal 2026 outlook. The company expects net sales of $13.40-$13.55 billion, indicating year-over-year growth of 6.3-7.5%. The guidance includes an estimated $70-million revenue contribution from Modern Animal during fiscal 2026.
While Modern Animal’s clinics generate attractive mature four-wall profitability, management expects the business to create a modest margin-rate drag during 2026 as integration efforts progress. Even so, Chewy maintained confidence in its earnings model and plans to open 10-12 Chewy Vet Care locations this year while integrating Modern Animal into its operating and technology platforms.
CHWY’s Price Performance, Valuation & EstimatesChewy, which competes with BARK, Inc. (BARK - Free Report) and Petco Health and Wellness Company, Inc. (WOOF - Free Report) , has fallen 22.8% in the past three months against the industry’s growth of 10%. Meanwhile, BARK shares have declined 20.4% and Petco has dipped 9.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a trailing price-to-sales ratio of 0.59X, below the industry’s average of 2.20X. It has a Value Score of A. CHWY is trading at a premium to BARK (with a trailing 12-month P/S ratio of 0.22) and Petco (0.12).
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CHWY’s fiscal 2026 and 2027 earnings implies year-over-year growth of 20.5% and 22.2%, respectively. Estimates for fiscal 2026 and 2027 have been revised downward by 10 cents and 13 cents, respectively, in the past 30 days.
